Does GILTERITINIB Cause Thrombocytopenia? 149 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 149 reports of Thrombocytopenia have been filed in association with GILTERITINIB (Xospata). This represents 4.1% of all adverse event reports for GILTERITINIB.
149
Reports of Thrombocytopenia with GILTERITINIB
4.1%
of all GILTERITINIB reports
26
Deaths
47
Hospitalizations
How Dangerous Is Thrombocytopenia From GILTERITINIB?
Of the 149 reports, 26 (17.4%) resulted in death, 47 (31.5%) required hospitalization, and 11 (7.4%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GILTERITINIB. However, 149 reports have been filed with the FAERS database.
What Other Side Effects Does GILTERITINIB Cause?
Acute myeloid leukaemia (366)
Febrile neutropenia (346)
Off label use (334)
Platelet count decreased (327)
Pneumonia (302)
Myelosuppression (300)
Pyrexia (281)
Death (206)
Product use issue (189)
Hepatic function abnormal (181)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which GILTERITINIB Alternatives Have Lower Thrombocytopenia Risk?
GILTERITINIB vs GIMERACIL\OTERACIL\TEGAFUR
GILTERITINIB vs GINKGO
GILTERITINIB vs GIVINOSTAT
GILTERITINIB vs GIVOSIRAN
GILTERITINIB vs GLASDEGIB